Human papillomavirus (HPV) types 6 and 11 are usually found in benign genital lesions and laryngeal papillomas. However, the occasional occurrence of their DNAs in carcinomas of the genital tract and larynx suggests that they have some tumorigenic activity. In this paper, we have examined the cotransforming and transactivation activities of the E7 genes from these virus types and show that they cooperate with ras to transform primary cells, but at a greatly reduced level compared to HPV-16 E7.
Introduction
The strong association between the DNAs of human papillomavirus (HPV) types 6 and 11 and genital and laryngeal papillomas suggests that they possess a mitogenic activity. Carcinomas associated with HPV-6 and -11 are very rare when compared to other virus types, although HPV-6b and a variant, termed HPV-6vc, have been isolated from vulvar carcinomas (Kasher & Roman, 1988; Rando et al., 1986) . The viral early region of the HPV types most commonly associated with cervical carcinomas, types 16, 18, 31 and 33, when placed under the transcriptional control of a strong heterologous promoter, are able to cooperate with activated ras Phelps et al., 1988) or fos (Crook et al., 1988) oncogenes to transform primary baby rat kidney (BRK) or baby mouse kidney epithelial cells. This co-transforming activity has been localized to the E7 gene, which was found to be as efficient as the entire early region of the virus in this assay Phelps et al., 1988) and is necessary for the maintenance of the transformed phenotype (Crook et al., 1989) . However, the early regions of HPV types 6 and 11 were found to be inactive in such experiments . There are three possible explanations for these findings. First, the E7 genes may have been expressed at a level which was too low to be effective or, second, expression was at normal levels but the proteins themselves were non-functional in these assays or, thirdly, some early protein other than E7 was produced and antagonized the activity of E7.
The oncogenic virus types such as HPV-16 appear to generate E7 mRNA by splicing events that cannot occur in the benign types 6 and 11 (Smotkin et al., 1989) . Splice donor and acceptor sites found within the E6 open reading frame (ORF) of HPV-16 and other malignant types are not present in either HPV-6 or HPV-11. To test whether the E7 ORFs of types 6 and 11 were functional in a co-transformation assay when isolated from the rest of the genome, we cloned the individual ORFs into the expression vector pJ4D (a gift from J. P. Morgenstern) and co-transfected these plasmids, plus an activated ras oncogene, into primary cultures of BRK ceils. These results show that the HPV-6 and -11 E70RFs are able to cooperate with ras to transform BRK cells, but with a greatly reduced efficiency, to give rise to cells that are tumorigenic in syngeneic immunocompetent animals. We then examined these genes for their ability to transactivate the adenovirus E2 promoter and show that the observed decrease in the co-transforming potential of these virus types does not correlate with the ability of a particular virus type to transactivate the adenovirus E2 promoter. This is the first demonstration that transfection of HPV-6 or HPV-I 1 DNA into primary epithelial cells can lead to malignant transformation. . The expression vector pJ4fZ was a gift from J. P. Morgenstern (Growth Control and Development Laboratory, Imperial Cancer Research Fund, U.K.) and plasmid constructions containing HPV-16,-18, -31 and -33 DNA were as previously described . HPV-6 DNA present in the BamHI site of pATI53 was cut with BamHI and MluI, yielding a 5-2 kb fragment, which was endrepaired, BamHl-linked and cloned into pJ4f~, forming the plasmid pJ4f~6. The entire HPV-11 genome present in a pSV2-neo vector was excised with BamHI and cloned into pJ4fL DNA fragments containing HPV-6 and HPV-11 E7 genes alone were as described later.
Transfection and selection. Cultures of primary BRK cells were prepared and transfected by the DNA-calcium phosphate coprecipitation method (Wiglet et al., 1979) . Samples of DNA-calcium phosphate precipitate (0-8 ml), containing 5 Ixg of each of the indicated plasmids, were added to 90 mm dishes of sub-confluent BRK cells. After glycerol treatment the cells were cultured in Dulbecco's modified Eagle's medium containing 500 p.g/ml G418. Three weeks after transfection colonies were either isolated with cloning rings and propagated as cell lines, or the cells were fixed in formal saline and stained using Giemsa stain.
Nucleic acid hybridization. Total genomic DNA was isolated from cell lines transfected with HPV DNA and EJ-ras. DNA samples (10 p.g) were digested with BamHI and electrophoresed on 1~ agarose gels and subjected to Southern transfer (Southern, 1975) using 0.4 M-NaOH (Reed & Mann, 1985) and Hybond-N filters (Amersham). Hybridizations were performed using 32p-labelled random primed (Feinberg & Vogelstein, 1983) HPV DNA fragments for 20 h. The filters were washed in 2 x SSC containing 0-1 ~ SDS (1 x SSC is 150 mM-NaCI, 15 mM-trisodium citrate pH 7-0) at room temperature, then in 0-2 x SSC and 0.1 ~ SDS at 55 °C and exposed to Fuji RX X-ray film with screens.
Total cellular RNA was isolated using guanidinium isothiocyanate (Chirgwin et al., 1979) and samples of glyoxylated RNA (10 ~tg) were electrophoresed on 1.2~ agarose gels and subjected to Northern blot analysis (Thomas, 1980) . Hybridizations were performed as described above.
lmmunoprecipitation. Sub-confluent 90 mm dishes of transfected cell lines were starved in medium without cysteine for 1 h and then labelled in medium containing 1 mCi [3sS]cysteine per plate. The cells were lysed in 250111 E7 extraction buffer (250 rnM-NaCl, 0. l ~ NP40, 50 mI~-HEPES pH 7-0, 1 ~ aprotinin) for 30 min on ice. Debris was removed by centrifugation at 13 000 g for 1 min. The supernatant was removed and E7 protein precipitated with an anti-E7 rabbit polyclonal serum (Smotkin & Wettstein, 1986) . Protein A-Sepharose (Pharmacia) was added and incubated at 4 °C for 1 h. Proteins bound to the beads were separated on 15~ PAGE gels, which were subjected to fluorography (Bonner & Laskey, 1974) , dried and exposed to Hyperfilm (Amersham).
Chloramphenicol acetyltransferase (CAT) assays. CAT assays were performed as previously described (Spalholz et al., 1985) in NIH 3T3 cells. The cells were lysed and the protein concentration was estimated with the Bio-Rad protein assay so that each CAT assay contained an equivalent amount of protein. The extracts were incubated with 0.5 ~tM-[~4C]chloramphenicol (53 Ci/mol) and 10 mM-acetyl CoA in 0-25 uTris-HCl pH 7.8. After a 2 h incubation at 37 °C the reaction products were separated by ascending thin-layer chromatography and localized by autoradiography. Acetylated chloramphenicol spots were excised for quantification by liquid scintillation. The CAT activity of an HPV sequence-containing plasmid is expressed as a percentage of the activity of the Ela plasmid pCE.
Transfection efficiencies were monitored by including into each transfection experiment 5 Ixg of the plasmid pCH110 (Hall et al., 1983) , which contains an Escherichia coil lacZ gene downstream of a simian virus 40 (SV40) promoter, fl-Galactosidase activity in the cell extracts was determined according to Miller (1972) and the results of each CAT assay are expressed as a function of the fl-galactosidase activity.
Results
Experiments using early region DNA derived from HPV types 16, 18, 31 and 33 transfected into primary BRK cells together with an activated ras oncogene showed that the major co-transforming region of these virus types was the E70RF, which was as active as the entire early region Phelps et al., 1988) . Repeated attempts to derive transformed colonies using early region DNA from types 6 and 11 failed . To investigate the co-transforming potential of the isolated E7 ORFs, expression vectors containing E7 DNA derived from HPV types 6 and 11 were generated. HPV-6 DNA present in the BamHI site of pAT153 was cut with NsiI, giving a 1.1 kb fragment (bp 530 to 1640); similarly, a 1.0 kb NsiI fragment of HPV-11 (bp 530 to 1580) was isolated from a genomic clone of HPV-11 present in the BamHI site of pSV2-neo. These NsiI fragments were linker-adapted such that both NsiI sites were regenerated and BamHI sites added at either end. These fragments were cloned into the expression vector pJ4f~, where the E7 ORF is under the transcriptional control of a strong heterologous promoter, the Moloney murine leukaemia virus (MoMLV) long terminal repeat (LTR). These plasmids were designated pJ4~)6. E7 and pJ4fll 1. ET, respectively. Construction of similar expression plasmids containing the E70RFs of HPV types 16, 18 and 33 have already been described . The E7 expression plasmids of types 6, 11 and 16 share a common NsiI site at the 5' end of the E70RF, but have differing endpoints within the E10RF (Fig. 1) . Fig. 2 . Transfection of primary BRK ceils with HPV DNA. All dishes were transfected with pSV2-neo plus pEJ6.6 (containing the Ha-ras oncogene cloned from the E J/T24 bladder carcinoma cell line) and the indicated plasmid in each case. Cultures were grown for 3 weeks after transfection in medium containing 500 p.g/ml G418, before fixing and staining.
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These E7-containing plasmids were transfected into BRK cells with an activated ras oncogene present on the plasmid pEJ6.6, which contains the activated Ha-ras oncogene derived from the T24 bladder carcinoma cell line (Shih & Weinberg, 1982) . The plasmid pSV2-neo (Southern & Berg, 1982) conferring G418 resistance was included in all transfection experiments. After glycerol shock treatment the cells were placed under G418 selection and colony formation was monitored for 3 to 4 weeks after transfection (Fig. 2) . Neither pEJ6.6 nor pSV2-neo gave rise to G418-resistant colonies and no colonies were detected if either plasmid was omitted from the experiment.
As shown in Table 1 , transfection of pJ4t)6. E7 or pJ4fil 1. E7 plus ras into BRK cells produced about 50 to 100-fold fewer G418-resistant colonies when compared to pJ4~)16. E7 and transfection of the entire early region of HPV-6 or HPV-11 in the plasmids pJ4~6 and pJ4f~l 1 repeatedly yielded no colonies, suggesting that the E7 ORFs of these HPV types possess a markedly lower co- transforming potential. It has been shown that high level expression of ras in G418-selected, rat embryo fibroblasts was able to induce tumorigenic conversion (Land et al., 1986) . However, no G418-resistant colonies were ever generated by transfection of ras plus pSV2-neo into predominantly epithelial cultures of primary B R K cells. Analysis of cells transfected by pJ4~)6. E7 and pJ4~) 11. E7 was performed on individually isolated and expanded colonies. Of eight HPV-6 E7 and ten HPV-11 E7 colonies chosen only one and two, respectively, were able to be propagated as cell lines, which have now been growing in cell culture for more than 6 months and show no sign of senescence. Typical growth curve analysis of these cell lines is shown in Fig. 3 . All three cell lines grew more slowly and attained lower saturation densities than cells transfected by HPV-16 E7 (Fig. 3) . Southern blot analysis of cell lines showed that they contained unrearranged copies of HPV-6 and -11 D N A (Fig. 4) and that the pJ4f~l 1.E7 clone 2 contained approximately 10 times more HPV-11 D N A than clone 1. Copy number analysis indicated that the pJ4f26. E7 and the pJ4f~l 1. E7 clone 1 cell lines possess one or two copies of integrated H P V D N A (data not shown). Northern blot analysis showed that the cell lines expressed type-specific transcripts ( Fig. 5) and that the pJ4f~ll.E7 clone 2 cell line expressed more m R N A than clone 1. The pJ4f~l 1.E7 cell lines both produced two species of m R N A , which were both under 18S (about 2 kb), whereas the pJ4~)6. E7 cell line also produced two m R N A species, but of between 18S and 28S (about 5 kb in length) (Fig. 5 ). We were also interested to see whether the cell lines produced any detectable E7 protein. Immunoprecipitation of [3SS]cysteine-labeUed proteins from these cell lines using a polyclonal serum raised against an HPV-16 E7 trpE fusion protein (Smotkin & Wettstein, 1986 ) is shown in Fig. 4 . Lanes 1 to 3 were probed with an HPV-6 genomic probe and lanes 4 to 6 with an HPV-11 genomic probe. the pJ4~6.E7 and pJ4O33.E7 cell lines. Proteins of about 15000 Mr immunoprecipitated from the two p J 4~l 1. E7 clones, and a protein of similar size to HPV-16 E7 from a cell line transformed by pJ4~31 plus ras (Fig. 6) , may be tentatively identified as HPV-11 E7 and HPV-31 E7 proteins, respectively.
Tumour production
It was important to determine whether the ceils produced by transfection of HPV-6 and -11 D N A s plus ras were tumorigenic in syngeneic immunocompetent animals. When 2 × 105 or 2 × 106 cells containing pJ4f~6.E7 or p J 4~l 1. E7 were injected subcutaneously into the flanks of each of four rats, no differences in the tumorigenic potential of these cells was observed when compared to pJ4O16.E7 cells. Tumours developed at the site of injection within 3 weeks in all cases.
Transactivational activities of HPV-6 and -11
The HPV-16 E7 protein has sequence homology with conserved E 1 a regions of the sequenced adenovirus types and can transactivate the adenovirus E2 promoter and presumably other, as yet unidentified, cellular genes. As HPVs share sequence . Immunoprecipitation analysis of [35Slcysteine-labelled proteins using an HPV-16 E7 polyclonal rabbit serum (Smotkin & Wettstein, 1986) . Lanes 1 to 6 were precipitated with anti-E7 serum and lanes 7 to 12 with pre-immune rabbit serum. BRK cell lines used were: lane 1, E I a/ras; lane 2, pJ4f216. E7/ras; lanes 3 and 8, pJ4f~6. E7/ras; lanes 4 and 9, pJ4~l 1. E7/ras clone 1 ; lanes 5 and 10, pJ4f~l 1. E7/ras clone 2; lanes 6 and 11, pJ4f~31/ras; lanes 7 and 12, pJ4D33. E7/ras. The arrow indicates the position of HPV-16 E7 in lane 2. homology throughout their E7 regions, we were interested to determine whether the decreased co-transforming activities o f HPV-6 and -I 1 E7s could be correlated with a decreased ability to transactivate the adenovirus E2 p r o m o t e r present in the plasmid pE2: : C A T (Murthy et al., 1985) . H P V E7 D N A s in pJ4~) were co-transfected with the p E 2 : : C A T plasmid into dishes of half-confluent N I H 3T3 cells. Following glycerol t r e a t m e n t the cells were grown for 48 h, harvested and assayed for C A T activity. The relative C A T activities of the different E7 constructs c o m p a r e d to a wild-type E l a , present on the plasmid p C E (Schneider et al., 1987) , are shown in Fig. 7 and Table 2. The virus types 16 and 33, which cooperated efficiently with ras to form G418-resistant colonies, also stimulated transcription of the E2 promoter. HPV-11 E7 was effective in the transactivation assay, despite its low co-transforming activity. It is therefore unlikely that papillomavirus co-transforming activity is simply a consequence of transactivation.
Discussion
Sequence homology between the E7 proteins of genital papillomaviruses (Cole & Danos, 1987) suggests that the HPV-6 and HPV-11 E7 proteins might be able to mediate cell transformation with ras, or to transactivate the adenovirus E2 promoter in a similar manner to oncogenic papillomaviruses (types 16, 18, 31 and 33) Storey et al., 1988) . The lack of cooperation between the entire early region of HPVs -6 and -11 may be due to a functionally inactive E7 protein in these types, or the E7 protein may be active but produced below a 'threshold' level needed for co-transformation. Using a keratinocyte assay, Schlegel et al. (1988) showed that in medium containing serum and calcium macrocolony formation was limited to HPV-16 and -18, but in low calcium HPV-6 and -11 could form micro-and macrocolonies. Recent studies have shown that oncogenic and non-oncogenic papillomaviruses generate functional E7 mRNA by different splicing mechanisms (Smotkin et al., 1989) , which could be important in determining the level of E7 protein. To avoid any differences due to splicing efficiency we have cloned the individual E70RFs from HPV types 6 and 11 directly behind a heterologous promoter, the MoMLV LTR and examined their transactivation and cotransforming activities. In the co-transfection experiments we show that HPV-6 E7 and HPV-11 E7 can cooperate with ras to transform primary BRK cells, but at a level 50-to 100-fold lower than HPV-16 E7 (Table 1) . Southern and Northern blot analysis of expanded colonies of pJ4~6.E7/ras and pJ4~ll.E7/ras cells showed the presence of expressed unrearranged HPV DNA. The pJ4f]ll.E7/ras clone 2 cells grew faster, contained more HPV DNA and expressed more E7 mRNA than the clone 1 cells, suggesting that the level of E7 gene expression may be important in determining the in vitro growth rate of these cells.
The pJ4~6.E7/ras and pJ4f]ll.E7/ras ceils were clearly transformed, as judged by their ability to form tumours in syngeneic immunocompetent rats within 3 weeks after injection. However, it was surprising that these cells generated tumours at the same rate as cells transformed by HPV-16 E7, as the ability of the HPV-6 and HPV-11 E7 genes to cooperate with ras to generate transformed colonies is massively reduced. The shared E7 protein sequence homology between papillomavirus types suggests that a polyclonal serum raised against HPV-16 E7 may cross-react with other E7 proteins.
Immunoprecipitation of [35S]cysteine-labelled proteins
showed that a protein of about 15000 Mr was specifically precipitated from pJ4~l 1 .E7/ras cells, suggesting that this may be the HPV-11 E7 protein. A protein of similar Mr to HPV-16 E7 could also be precipitated from pJ4f231. E7/ras cells, but the equivalent protein could not be detected in pJ4~6.E7/ras or pJ4f~33.E7/ras cells (Fig. 6 ). This may be because some epitopes that are present on HPV-16 E7 are absent from these E7 proteins. Type-specific sera or monoclonal antibodies will be needed to verify the identity of all these E7 proteins.
Having established that HPV-6 E7 and HPV-11 E7 could generate malignantly transformed cells we then examined the ability of these DNAs to transactivate the adenovirus 2 promoter, to see whether the transcriptional stimulatory activities of E7 are important for its role in cell transformation. Neither E7 nor E 1 a seems to bind to DNA directly (Feldman et al., 1982; Ferguson et al., 1985) . Ela proteins contain three distinct regions, which are strongly conserved amongst adenovirus types (van Ormondt et al., 1980; Kimelman et al., 1985) . Mutations in conserved regions 1 and 2, which are homologous to papillomavirus E7 N-terminal sequences, interfere with the ability of Ela to immortalize primary cells, to collaborate with ras in transformation and to induce cellular DNA synthesis, but are not required for transactivation (Lillie et al., 1986 (Lillie et al., , 1987 Moran et al., 1986) . Ela conserved region 3, which does not have an E7 homologue, is important and on its own can be sufficient for transactivation of early promoters (Glenn & Ricciardi, 1985; Lillie et al., 1986) . In similar mutagenesis studies Schneider et al. (1987) suggested that transactivation was unlikely to play an important role in transformation by E 1 a, as they were able to isolate mutants that could transform but not transactivate. They further suggested that Ela-mediated transformation occurs by repression of a cellular enhancer. Here we have shown that the ability of a particular viral E7 to transactivate is not always accompanied by an equivalent ability to co-transform, thus separating these two activities of E7 to a large extent. The results further suggest that not only splicing events within the E6 ORF but also the activity of the E7 protein itself are important in determining the oncogenic potential of a particular virus type.
These co-transformation assays show both qualitative and quantitative differences in the oncogenic potential of these genital papillomaviruses. The occurrence of HPV-6 and HPV-11 in vulvar and laryngeal carcinomas is rare and this is paralleled in vitro, where greatly diminished co-transforming activities of these types are observed, yet the HPV-6 E7-and HPV-I1 E7-transformed cells are as tumorigenic as cells transformed by HPV-16 E7. Further investigation of the overall structure of these E7 proteins and their interaction with other cellular factors will be necessary to understand the role of E7 in cellular transformation.
